Evidence map›Paper›PMID 40862827›Full record

ReviewCurrent oncology (Toronto, Ont.)2025

Lung Carcinoids in Adolescents and Young Adults (AYAs): A Still Overlooked Clinical Entity.

Alice Laffi, Laura Pala, Chiara Catania, Marzia Locatelli, Priscilla Cascetta, Emilia Cocorocchio, Giovanni Luca Ceresoli, Daniele Laszlo, Flaminia Facella, Emily Governini and 4 more

Abstract readReview
In one paragraph

Review in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alice LaffiDivision of Medical Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy.ORCID 0000-0001-7458-3366
Laura PalaDivision of Medical Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy.
Chiara CataniaDivision of Medical Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy.ORCID 0009-0008-2926-4663
Marzia LocatelliDivision of Medical Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy.
Priscilla CascettaDivision of Medical Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy.
Emilia CocorocchioDivision of Medical Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy.
Giovanni Luca CeresoliDivision of Medical Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy.
Daniele LaszloDivision of Medical Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy.
Flaminia FacellaDivision of Medical Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy.
Emily GoverniniDivision of Medical Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy.
Marzia BendoniDivision of Medical Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy.
Giuseppe PelosiDepartment of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.ORCID 0000-0003-4725-4692
Fabio ConfortiDivision of Medical Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy.
Tommaso Martino De PasDivision of Medical Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy.ORCID 0000-0001-5684-5254

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary carcinoids (PCs) are rare neoplasms involving typical and atypical carcinoids (TCs and ACs), defined histologically by absent or focal necrosis and mitotic counts (<2/mm

Indexed as

Carcinoid TumorLung NeoplasmsAdolescentHumansYoung AdultAYAlung carcinoidsNETsneuroendocrine tumors

Identifiers

PMID40862827
PMCPMC12385658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.